Lexpos News

NHS England (NHSE) have approved the patient group direction (PGD) for use by community pharmacy owners during the forthcoming flu vaccination season. This follows publication of the national protocol earlier in the week by the UK Health Security Agency. The publication of both documents, follows updates to the flu service specification following the amendment to [...]

The post Flu vac: PGD and national protocol published appeared first on Community Pharmacy England.

Drug alert number: EL (24)A/26 Date issued: 04 July 2024 Kent Pharma UK is recalling various batches of Itraconazole 10mg/ml Oral Solution as a precautionary measure due to out of specification in the appearance of the solution, particularly the presence of suspended particles or clusters of crystals: Itraconazole 10mg/ml Oral Solution (Kent Pharma UK) PL [...]

The post MHRA Class 2 Medicines Recall: Itraconazole 10mg/ml Oral Solution (Kent Pharma UK) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has redetermined the July 2024 reimbursement price for Naltrexone 50mg tablets (28) listed in Category A of the Drug Tariff. The basic price for this product should be £82.15 instead of £774.23 as published in the July Drug Tariff. This pricing issue was caused by a data [...]

The post July 2024 reimbursement price change for Naltrexone 50mg tablets appeared first on Community Pharmacy England.

Community Pharmacy England CEO Janet Morrison has given a video update on Pharmacy First, addressing some of the concerns that pharmacy owners have, particularly around the thresholds for monthly payments. In her video message, Janet notes the incredible early achievements of Pharmacy First as well as outlining the importance of the service and how it [...]

The post Pharmacy First Update: A message from our CEO appeared first on Community Pharmacy England.

Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) Drug alert number: EL (24)A/25 Date issued: 02 July 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) [...]

The post MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) appeared first on Community Pharmacy England.